Search Page

1

Cite

Share

Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.

Wijbrandts CA, Tak PP. Wijbrandts CA, et al. Mayo Clin Proc. 2017 Jul;92(7):1129-1143. doi: 10.1016/j.mayocp.2017.05.009. Mayo Clin Proc. 2017. PMID: 28688467 Free article. Review.

Cite

Share

2

Cite

Share

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.

Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, Atiqi S, van Vollenhoven R, Lems WF, Bos WH, Wijbrandts CA, Gerritsen M, Krieckaert C, Voskuyl AE, van der Horst-Bruinsma IE, Tas SW, Boers M, Rispens T, Nurmohamed MT, Wolbink G. Boekel L, et al. Among authors: wijbrandts ca. Lancet Rheumatol. 2022 May;4(5):e310-e313. doi: 10.1016/S2665-9913(22)00009-1. Epub 2022 Feb 8. Lancet Rheumatol. 2022. PMID: 35156061 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis.

Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP, Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B, Fautrel B, Chollet-Martin S, Gleizes A, Donnellan N, Deisenhammer F, Davidson J, Hincelin-Mery A, Dönnes P, Fogdell-Hahn A, De Vries N, Huizinga T, Abugessaisa I, Saevarsdottir S, Hacein-Bey-Abina S, Pallardy M, Broët P, Mariette X; ABIRISK Consortium. Quistrebert J, et al. Among authors: wijbrandts ca. Semin Arthritis Rheum. 2019 Jun;48(6):967-975. doi: 10.1016/j.semarthrit.2018.10.006. Epub 2018 Oct 12. Semin Arthritis Rheum. 2019. PMID: 30420245

Cite

Share

4

Cite

Share

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab.

Herenius MM, Thurlings RM, Wijbrandts CA, Bennink RJ, Dohmen SE, Voermans C, Wouters D, Izmailova ES, Gerlag DM, van Eck-Smit BL, Tak PP. Herenius MM, et al. Among authors: wijbrandts ca. Ann Rheum Dis. 2011 Jun;70(6):1160-2. doi: 10.1136/ard.2010.141549. Epub 2011 Feb 22. Ann Rheum Dis. 2011. PMID: 21345816 Free PMC article.

Cite

Share

5

Cite

Share

Body mass index and clinical response to infliximab in rheumatoid arthritis.

Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP. Klaasen R, et al. Among authors: wijbrandts ca. Arthritis Rheum. 2011 Feb;63(2):359-64. doi: 10.1002/art.30136. Arthritis Rheum. 2011. PMID: 21279992 Free article.

Cite

Share

6

Cite

Share

Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.

Klaasen R, Wijbrandts CA, van Kuijk AW, Pots D, Gerlag DM, Tak PP. Klaasen R, et al. Among authors: wijbrandts ca. Ann Rheum Dis. 2012 Jul;71(7):1260-1. doi: 10.1136/annrheumdis-2011-200741. Epub 2012 Feb 17. Ann Rheum Dis. 2012. PMID: 22345123 No abstract available.

Cite

Share

7

Cite

Share

Characteristics of synovial inflammation in early arthritis analysed by pixel-by-pixel time-intensity curve shape analysis.

van de Sande MG, van der Leij C, Lavini C, Wijbrandts CA, Maas M, Tak PP. van de Sande MG, et al. Among authors: wijbrandts ca. Rheumatology (Oxford). 2012 Jul;51(7):1240-5. doi: 10.1093/rheumatology/kes011. Epub 2012 Feb 28. Rheumatology (Oxford). 2012. PMID: 22375037

Cite

Share

8

Cite

Share

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms.

Bartelds GM, Wijbrandts CA, Nurmohamed MT, Wolbink GJ, de Vries N, Tak PP, Dijkmans BA, Crusius JB, van der Horst-Bruinsma IE. Bartelds GM, et al. Among authors: wijbrandts ca. Arthritis Rheum. 2009 Aug;60(8):2541-2. doi: 10.1002/art.24709. Arthritis Rheum. 2009. PMID: 19644871 Free article. No abstract available.

Cite

Share

9

Cite

Share

The features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria.

van de Sande MG, de Hair MJ, Schuller Y, van de Sande GP, Wijbrandts CA, Dinant HJ, Gerlag DM, Tak PP. van de Sande MG, et al. Among authors: wijbrandts ca. PLoS One. 2012;7(5):e36668. doi: 10.1371/journal.pone.0036668. Epub 2012 May 4. PLoS One. 2012. PMID: 22574210 Free PMC article.

Cite

Share

10

Cite

Share

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.

Boekel L, Hooijberg F, Vogelzang EH, Besten YR, Leeuw M, Atiqi S, van Vollenhoven RF, Wijbrandts CA, Gerritsen M, Krieckaert C, Dijkshoorn B, Bakhlakh S, Crooijmans JJ, Voskuyl A, van der Horst-Bruinsma IE, Lems W, Kuijpers TW, van Ham SM, Wieske L, Eftimov F, Kummer LY, van Dam PK, Stalman EW, Steenhuis M, Keijzer S, Cristianawati O, Keijser J, Loeff FC, Tas SW, Nurmohamed MT, Boers M, Rispens T, Wolbink G. Boekel L, et al. Among authors: wijbrandts ca. RMD Open. 2022 Apr;8(1):e002035. doi: 10.1136/rmdopen-2021-002035. RMD Open. 2022. PMID: 35383121 Free PMC article.

Cite

Share